Schedule 13D ownership disclosure
ATARA BIOTHERAPEUTICS INC
Common Stock, par value $0.0001 per share · CUSIP: 046513107
Event date: 2025-05-14
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Adiumentum Capital Fund I LPReported CIK 0002023734
Shares: 1,370,081.00 · Class: 19.99%
- Adiumentum Capital Fund I GP LLCReported CIK 0002023736
Shares: 1,370,081.00 · Class: 19.99%
- Gregory A. CiongoliReported CIK 0002023732
Shares: 1,370,081.00 · Class: 19.99%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-050119
- Form type
- SCHEDULE 13D/A
- Filer
- Adiumentum Capital Fund I LP
- CIK
- CIK 2023734
- Filed
- May 16, 2025
- Reporting period
- May 14, 2025
- Description
- Schedule 13D beneficial ownership